Bioinformatics Services Market Size, Share and Growth Outlook, 2026

Bioinformatics Services Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Bioinformatics Services Market size is forecast to increase from $5.12 Billion in 2026 to $14.71 Billion in 2034 at a CAGR of 14.1% between 2026 and 2034.

The Bioinformatics Services market report provides detailed analysis and outlook of Bioinformatics Services segments including By Service Type (Data Analysis & Interpretation, Sequencing Services, Database & Management Services, Consulting & Training Services), By Application (Drug Design, Clinical Diagnostics, Personalized Medicine, Systems Biology, Comparative Genomics), By End-User (Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations, Academic Institutions) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Bioinformatics Services Industry Overview

Growing Demand for Outsourced Bioinformatics Expertise

The bioinformatics services industry is expanding rapidly as pharmaceutical companies, biotechnology firms, academic research institutions, and clinical organizations seek specialized computational support for increasingly complex biological datasets. The widespread adoption of next-generation sequencing, multi-omics research, spatial biology, and digital health technologies has created a growing need for advanced data analysis capabilities. Many organizations are turning to outsourced bioinformatics service providers to access sophisticated computational infrastructure, specialized expertise, and scalable analytical resources without making substantial investments in internal information technology and bioinformatics teams. This trend is driving the growth of service-based models across the life sciences sector.

Cloud-Based Bioinformatics Platforms Enhancing Accessibility

Cloud computing is becoming a central component of bioinformatics service delivery. Thermo Fisher Scientific expanded its Connected Workspace offering, a cloud-based service that provides outsourced bioinformatics analysis to smaller biotechnology companies. The platform enables organizations to process genomic datasets using high-performance computational resources without requiring extensive in-house infrastructure or specialized information technology expertise. By providing access to advanced analytical capabilities through a service-based model, cloud-enabled bioinformatics platforms are helping smaller research organizations participate more effectively in genomics, precision medicine, and molecular biology programs.

Spatial Transcriptomics Creating New Service Opportunities

The increasing adoption of spatial biology technologies is generating demand for specialized bioinformatics services. 10x Genomics expanded its bioinformatics analysis offerings to support interpretation of spatial transcriptomics data generated by advanced tissue imaging platforms. This initiative addresses a significant challenge faced by academic and industrial laboratories, where large volumes of complex three-dimensional tissue data create substantial analytical bottlenecks. By providing dedicated analysis services for spatial transcriptomics applications, bioinformatics providers are helping researchers transform intricate biological imaging data into actionable insights related to cellular interactions, disease mechanisms, and tissue organization.

Bioinformatics-as-a-Service Supporting Decentralized Clinical Research

Contract research organizations are increasingly incorporating bioinformatics-as-a-service models into their clinical research offerings. Organizations such as LabCorp are promoting bioinformatics services designed to support decentralized clinical trials and digital health studies. These services focus on validating the clinical relevance of digital biomarkers collected from wearable devices, remote patient monitoring systems, and connected healthcare technologies. As decentralized clinical trial models become more prevalent, bioinformatics service providers are playing a critical role in analyzing large-scale patient-generated data, ensuring data quality, and translating digital health measurements into clinically meaningful endpoints. This evolution is expanding the role of bioinformatics services beyond traditional genomics into broader areas of digital medicine and real-world evidence generation.

Bioinformatics Services Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Bioinformatics Services market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- IQVIA Inc., Labcorp (Laboratory Corporation of America), Charles River Laboratories, Eurofins Scientific, WuXi AppTec, Illumina, Inc., Source BioScience, NeoGenomics Laboratories, BGI Group, MedGenome. The Bioinformatics Services market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Bioinformatics Services industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Bioinformatics Services Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Bioinformatics Services companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Bioinformatics Services markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Bioinformatics Services Market Competitive Benchmarking and Company Analysis

Leading companies in Bioinformatics Services industry include- IQVIA Inc., Labcorp (Laboratory Corporation of America), Charles River Laboratories, Eurofins Scientific, WuXi AppTec, Illumina, Inc., Source BioScience, NeoGenomics Laboratories, BGI Group, MedGenome. The Bioinformatics Services market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Bioinformatics Services Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Bioinformatics Services market remains one of the strongest-performing segments in the country.
The US Bioinformatics Services Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Bioinformatics Services market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Bioinformatics Services industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Bioinformatics Services markets

Canada's strong Bioinformatics Services sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Bioinformatics Services market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Bioinformatics Services Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Bioinformatics Services market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Bioinformatics Services population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Bioinformatics Services industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Bioinformatics Services market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Bioinformatics Services sales through 2034

France Bioinformatics Services companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Bioinformatics Services Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Bioinformatics Services distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Bioinformatics Services Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Bioinformatics Services market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Bioinformatics Services industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Bioinformatics Services industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Bioinformatics Services Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Bioinformatics Services market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Bioinformatics Services market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Bioinformatics Services Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Bioinformatics Services Market Segmentation

By Service Type
Data Analysis & Interpretation
Sequencing Services
Database & Management Services
Consulting & Training Services
By Application
Drug Design
Clinical Diagnostics
Personalized Medicine
Systems Biology
Comparative Genomics
By End-User
Pharmaceutical Companies
Biotechnology Firms
Contract Research Organizations
Academic Institutions

Top Companies in Bioinformatics Services Industry

IQVIA Inc.
Labcorp (Laboratory Corporation of America)
Charles River Laboratories
Eurofins Scientific
WuXi AppTec
Illumina, Inc.
Source BioScience
NeoGenomics Laboratories
BGI Group
MedGenome

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025